Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hepatitis × Methylprednisolone Hemisuccinate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Leukemia 11 Leukemia, Myeloid, Acute 8 Lymphoma 6 Myelodysplastic Syndromes 5 Lymphoma, Non-Hodgkin 5 Burkitt Lymphoma 5 Blast Crisis 5 Multiple Myeloma 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myelomonocytic, Juvenile 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Accelerated Phase 3 Dendritic Cell Sarcoma, Interdigitating 3 Waldenstrom Macroglobulinemia 2 Neoplasms 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, B-Cell 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hematologic Neoplasms 2 Graft vs Host Disease 2 Congenital Abnormalities 2 Wilms Tumor 1 Skin Neoplasms 1 Shwachman-Diamond Syndrome 1

Interventions

Blood Specimen Collection 2 bavituximab 1 Ursodeoxycholic Acid 1 Surveys and Questionnaires 1 Steroids 1 Spermine Synthase 1 Sorafenib 1 Sofosbuvir 1 Ribavirin 1 Prednisone 1 Phlebotomy 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Liquid Biopsy 1 Clinical Protocols 1 Adrenal Cortex Hormones 1 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡